The "Artificial Intelligence In Pharmaceutical Market Report by Technology, Offering, Application, Deployment Mode, Countries and Company Analysis, 2025-2033" report has been added to ...

The agreement with Algen Biotechnologies gives AstraZeneca exclusive rights to develop and commercialise therapies from the ...

Biogenetics company Klotho Neurosciences has announced plans to acquire certain assets from Turn Biotechnologies.

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

AI and ML enhance drug discovery by rapidly screening compounds and predicting ADMET properties, reducing resource commitment and de-risking projects. Digital tools bridge R&D and manufacturing, ...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc.

Genmab has signed an agreement to buy all shares of Merus at $97 per share, in an all-cash transaction valued at $8bn.

Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...